Zhujiang Hospital

This study is testing if a drug called luspatercept is safe and can help treat anemia (low red blood cells) in people who have had a stem cell transplant for acute leukemia. The main goal is to see if the drug can increase hemoglobin levels enough to reduce the need for blood tra…

This study is testing whether a combination of two drugs, azacitidine and chidamide, can help keep high-risk acute myeloid leukemia (AML) from coming back after a patient has received a stem cell transplant from a donor. The main goals are to see if this maintenance therapy is sa…

This study is testing a combination treatment to prevent liver cancer from coming back after surgery in patients at high risk of recurrence. It combines a targeted liver procedure (TACE) with an oral medication (icaritin). The main goal is to see if this approach helps patients s…

This study is testing whether gentle electrical stimulation of nerves in the ear can help patients with severe brain injuries regain consciousness. Twenty patients in a vegetative or minimally conscious state will receive this non-invasive stimulation twice daily for 10 days. Res…

This study is testing a new artificial intelligence (AI) system designed to help doctors diagnose chronic kidney disease from biopsy images. Researchers will collect kidney biopsy images from about 2,900 patients. They will compare the AI system's diagnosis to the expert diagnosi…

This study is testing a blood test that looks for tiny traces of leftover cancer DNA after surgery for liver cancer. Researchers want to see if this test can predict if the cancer will come back, and if it can detect this return earlier than standard imaging scans like CT or MRI.…

This study aims to understand how the community of bacteria in the mouth changes when patients with advanced oral cancer receive a combination of chemotherapy and immunotherapy before surgery. Researchers will follow 32 patients to see if these bacterial changes are linked to how…